20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
MODIFIED PROCEDURE FOR CONTROLLED OVARIAN STIMULATION AND INTRAUTERINE INSEMINATION
#2402CO-ACTIVATION OF MTOR AND STAT3 PATHWAYS TO PROMOTE NEURONAL SURVIVAL AND REGENERATION
#2403Modified Friedreich ataxia genes and vectors for gene therapy
#2404PROLACTIN RECEPTOR ANTAGONISTS FOR TREATMENT OF GLIOBLASTOMA
#2405STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS
#2406Treatment of autoimmune and/or inflammatory disease using novel caveolin modulators
#2407Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#2408Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog
#2409Composition and method for the treatment or prevention of spinal disorders
#2410Method of reducing the likelihood of skin cancer in an individual human being
#2411MESENCHYMAL STEM CELL-DERIVED EXOSOMES AND THEIR USES
#2412Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2
#2413Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target
#2414Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
#2415Polypeptide-polymer conjugates and methods of use thereof
#2416Constructs having a SIRP-α domain or variant thereof
#2417Met e 1 tropomyosin variants for use in allergen-specific immunotherapy
#2418ACTH prophylactic treatment of renal disorders
#2419STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
#2420Prodrug Comprising a Drug Linker Conjugate
#2421Use of CPNE7 for differentiating non-dental mesenchymal stem cells into odontoblasts, regenerating dental pulp and treating dentin hypersensitivity
#2422Immediate-release tablet formulation, composition for tablets and method for manufacturing immediate-release tablet formulation
#2423Methods and compositions for immunomodulation
#2424USING HEAT SHOCK PROTEINS TO IMPROVE THE THERAPEUTIC BENEFIT OF A NON-VACCINE TREATMENT MODALITY
#2425Inhibition of endosomal toll-like receptor activation
#2426Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling
#2427Fibronectin based scaffold domain proteins that bind to myostatin
#2428Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
#2429Delivery of Nrf2 as therapy for protection against reactive oxygen species
#2430Endogenous neogenesis of beta cells
#2431Gene therapy for neurodegenerative disorders
#2432Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active ingredient
#2433METHODS OF IMPROVING NUCLEASE MEDIATED HOMOLOGOUS RECOMBINATION
#2434RTEF-1 variants and the use thereof for inhibition of angiogenesis
#2435Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide
#2436REGULATION OF SODIUM CHANNELS BY PLUNC PROTEINS
#2437Method of treating fulminant hepatic failure using DLL4 cytokine
#2438Compositions and methods for modulating the immune system
#2439Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD)
#2440Technology for the Preparation of Microparticles
#2441Hydrogel toxin-absorbing or binding nanoparticles
#2442Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
#2443Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same
#2444Methods of treatment using hemopexin compositions
#2445Method of promoting wound healing with hyodxia-induced mitogenic factor
#2446NANOPARTICLE AGGREGATES CONTAINING OSTEOPONTIN AND CALCIUM- AND/OR STRONTIUM-CONTAINING PARTICLES
#2447METHODS FOR MANAGING CARE OF PATIENTS PREDISPOSED TO PROGRESSIVE MITRAL VALVE DISEASES
#2448Composition for inducing direct transdifferentiation into oligodendrocyte progenitor cells from somatic cells and use thereof
#2449Enhancement of osteogenic potential of bone grafts
#2450Detecting a therapeutic cell
#2451Peptides of syndecan-1 for inhibiting angiogenesis
#2452Implants having a drug load of an oxysterol and methods of use
#2453Natural tissue scaffolds as tissue fillers
#2454Stable formulations for parenteral injection of peptide drugs
#2455Methods for treating myocardial infarction comprising administering sonic hedgehog
#2456Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival
#2457Methods of altering bone growth by administration of Sost or Wise antagonist or agonist
#2458Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
#2459Methods and compositions relating to P62 for the treatment and prophylaxis of cancer
#2460Compositions and methods for modulating stem cells and uses thereof
#2461Stable MIA/CD-RAP formulation
#2462Use of peptide for treating angiogenesis-related diseases
#2463Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity
#2464Isoform nell-1 peptide
#2465Sensorineural hair cell differentiation
#2466STY PEPTIDES FOR INHIBITION OF ANGIOGENESIS
#2467Biomarkers for painful intervertebral discs and methods of use thereof
#2468COMPOSITION TO REPURPOSE DRUGS
#2469Apolipoprotein O and fragments thereof for inducing apoptosis in a cancerous cell
#2470Treatment of myotonic dystrophy
#2471Liquid enteral nutritional composition with a low monovalent metal ion content
#2472Methods and compositions for treating Huntington's Disease
#2473Bioerodible silicon-based devices for delivery of therapeutic agents
#2474Mutant huntingtin-mediated protein dysfunction
#2475Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#2476Suppression of allergic lung inflammation and hyperreactivity
#2477T-cell redirecting bispecific antibodies for treatment of disease
#2478Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods
#2479METHODS AND COMPOSITIONS USING FRESH OR FROZEN MEAT TO IMPROVE FOOD EFFICIENCY IN ANIMALS SUCH AS DOGS
#2480Methods and compositions comprising tau oligomers
#2481Sumoylation of SERCA2a and cardiovascular disease
#2482Peptides derived from NCAPG2 and their use
#2483Therapeutic applications of Smad7
#2484NEURONAL VIABILITY FACTOR AND USE THEREOF
#2485FREE RAPTOR REDUCES AGING- AND OBESITY-INDUCED FATTY LIVER
#2486Implants having a high drug load of an oxysterol and methods of use
#2487METHODS AND COMPOSITIONS FOR GENE DELIVERY TO ON BIPOLAR CELLS
#2488Glycotargeting therapeutics
#2489Compositions and methods to promote wound healing
#2490PEPTIDE-MEDIATED DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#2491Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
#2492FGFR inhibitor for use in the treatment of hypophosphatemic disorders
#2493MOLECULE ASSOCIATED WITH ONSET OF GOUT, AND METHOD AND KIT FOR EVALUATING DIATHESIS OF URIC ACID-RELATED DISEASES AND INFLAMMATION-RELATED DISEASES, AND INSPECTION OBJECT AND DRUG
#2494DNA vaccines encoding heat shock proteins
#2495Target for diabetes treatment and prevention
#2496CD300A RECEPTORS AS VIRUS ENTRY COFACTORS
#2497HUMAN FERTILITY ENHANCEMENT WITH CORTISOL REDUCTION FOOD
#2498LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE
#2499METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONS
#2500Peptides and compositions for treatment of joint damage
#2501Polypeptides to inhibit epstein barr viral protein BHRF1 and B cell lymphoma family proteins
#2502Adeno-associated virus virions with variant capsid and methods of use thereof
#2503Adeno-associated virus virions with variant capsid and methods of use thereof
#2504RNA preparations comprising purified modified RNA for reprogramming cells
#2505Method of preventively treating a subject at the risk of developing infections of a respiratory virus
#2506Compound, use, anti-tumor pharmaceutical composition, gene construct for polypeptide expression, process for the production, process for the evaluation of tumor cells, method of sensitization of tumor cells to chemotherapeutic
#2507Methods for treating disorders that involve immunoglobulin A
#2508Compositions and methods for treating cancer
#2509Method of treating cancer using IL2R beta/common gamma chain antibodies
#2510Modulation of cellular localization of cyclin C
#2511Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers
#2512Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
#2513Modification and compositions of human secretoglobin proteins
#2514Treatment of retinal degeneration using gene therapy
#2515METHOD FOR TREATING ALZHEIMER'S DISEASE USING SUPERIOR STABILITY TUBULIN CONSRUCTS
#2516COSMETIC USE OF DERMICIDIN, OR ANALOGUES OR FRAGMENTS THEREOF, FOR THE PREVENTION AND/OR TREATMENT AND DIAGNOSIS OF OILY SKIN AND AESTHETIC SKIN DISORDERS ASSOCIATED THEREWITH
#2517Liquid nutritional formula for tyrosinemia patients
#2518Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
#2519COMPOSITIONS AND METHODS FOR MODULATION OF IMMUNE RESPONSE
#2520Compositions and Formulations for Increasing Renal Function and Treatment and Prevention of Renal Diseases, and Methods of Production and Use Thereof
#2521Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema
#2522COMPOSITIONS OF POLYUNSATURATED FATTY ACIDS AND METHODS OF USE THEREOF
#2523Methods for detecting expression levels of human signal peptide-containing proteins (HSPP)
#2524Compositions and methods to modulate cell activity
#2525Targeted oesophageal administration of ZN-α-glycoproteins (ZAG), methods and formulations thereof
#2526COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A BONE CONDITION
#2527PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION
#2528miR-211 expression and related pathways in human melanoma
#2529FKBP-L polypeptides and uses in angiogenesis-mediated disorders
#2530TRANSMUCOSAL AND TRANSEPITHELIAL DRUG DELIVERY SYSTEM
#2531Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#2532Method of diagnosis, prognostic or treatment of neurodegenerative disease
#2533Targeted therapy for small cell lung cancer
#2534METHOD FOR INCREASING THE BIOAVAILABILITY OF INHALED COMPOUNDS
#2535Application of YB-1 protein and fragments thereof for preparing medicinal agents in treating alzheimer's disease
#2536Selectively targeted antimicrobial peptides and the use thereof
#2537Treatment and diagnosis of melanoma
#2538WATER-IN-OIL TYPE EMULSION FOR TREATING A DISEASE OF THE EYE
#2539Methods, kits and devices for promoting cardiac regeneration
#2540Inhibitor targeting specific complement system, and preparation method and use thereof
#2541Isolated nucleotide sequences encoding GDF traps
#2542Anti-tumor properties of Dickkopf 3b
#2543Reversible pegylated drugs
#2544METHODS AND APPARATUS FOR CREATING PARTICLE DERIVATIVES OF HDL WITH REDUCED LIPID CONTENT
#2545COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX
#2546Apolipoprotein A-I mimics
#2547Beta-casein A2 and blood glucose levels
#2548TREATMENT OF EYE DISEASE
#2549Casein peptide for use in the treatment of uterine infections
#2550Cationic polymers as co-drugs for chemotherapeutic agents
#2551DRG11-RESPONSIVE (DRAGON) GENE AND USES THEREOF
#2552Pharmaceutical compositions targeting WNT pathway proteins
#2553T CELL MODULATOR
#2554Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
#2555Method of predicting a response to an anti-tumor treatment
#2556Reduction of lipase activity in product formulations
#2557HYDROXYALKYL STARCH DERIVATIVES AS REACTANTS FOR COUPLING TO THIOL GROUPS
#2558Removal of serine proteases by treatment with finely divided silicon dioxide
#2559Constructs Binding to Phosphatidylserine and Their Use in Disease Treatment and Imaging
#2560Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject
#2561TUSC2 THERAPIES
#2562Therapeutic method of treatment for inhibiting tumor development using Tamm-Horsfall glycoprotein (THP) as immunostimulating drug and compositions
#2563COMPOSITIONS FOR INHIBITING VIRAL REPLICATION AND METHODS OF USE AND PRODUCTION THEREOF
#2564Treatment of gum diseases and gum disorders with TSG-6 protein
#2565COMPOSITIONS AND METHOD FOR CONTROLLING INFECTIONS IN NON-HUMAN MAMMALS USING ACUTE PHASE PROTEINS
#2566Wnt compositions and methods for purification
#2567Recombinant lubricin composition
#2568Pharmaceutical compositions and methods for the treatment of metastatic cancer
#2569Inhibition of collagen synthesis
#2570Modular particles for immunotherapy
#2571Composition and method for therapeutic agent delivery during pregnancy
#2572Application of irisin in myocardial ischemia reperfusion
#2573Liquid milk fortifier composition with relatively high lipid content
#2574METHOD FOR MODULATING APPETITE
#2575Selective PYY compounds and uses thereof
#2576Antimicrobial agents and their use in therapy
#2577Modified therapeutic agents and compositions thereof
#2578Treatment for dupuytren's disease
#2579ANTICALINS
#2580Methods and compositions for inhibiting oxidative stress
#2581Annexin II variant compositions and methods
#2582Suppression of cellular transformation and dysplasia by topical application of lefty
#2583Histatin for corneal wound healing and ocular surface disease
#2584Immunosuppressive agents and their use in therapy
#2585Transduction buffer
#2586TISSUE INHIBITOR OF METALLOPROTEINASES (Timp) LINKED TO GLYCOSYLPHOSPHATIDYLINOSITOL (Gpi) - ANCHORS FOR TREATMENT OF CANCER AND SKIN LESIONS
#2587Methods for treating hepatitis C virus infectious disease
#2588Methods of treating heart failure with agonists of hypocretin receptor 2
#2589Reelin rescues cognitive function
#2590Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use
#2591Compositions comprising perivascular stem cells and nell-1 protein
#2592Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming
#2593PROTEIN-SPECIFIC FORMULATIONS
#2594Compositions and methods for protecting the kidney from ischemia reperfusion injury
#2595Methods of using myelin basis protein peptide compositions
#2596Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
#2597PIF-TRANSFECTED CELLS AND METHODS OF USE
#2598Modified binding proteins inhibiting the VEGF-A receptor interaction
#2599METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1
#2600Compositions comprising semaphorins for the treatment of cancer and methods of selection thereof
#2601Use of Hsp70 as a regulator of enzymatic activity
#2602HUMAN FIBROLAMELLAR HEPATOCELLULAR CARCINOMAS (hFL-HCCS)
#2603REGULATION OF NPVF GENE AND ITS PRODUCTS: A METHOD FOR MODULATING ENERGY IMBALANCE
#2604Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins
#2605Muteins of tear lipocalin and methods for obtaining the same
#2606Methods for treating spinocerebellar ataxia type I using RPA1
#2607Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
#2608Nerve regenerating or nerve growth-promoting pharmaceutical composition containing Vax protein as active ingredient
#2609Control of rheological properties of mixed hyaluronate/lubricin solutions
#2610NEUROPROTECTIVE PEPTIDES
#2611Combination immunotherapy for the treatment of cancer
#2612Peptides and compositions for treatment of joint damage
#2613Bioerodible silicon-based devices for delivery of therapeutic agents
#2614METHODS AND COMPOSITIONS FOR THE REDUCTION OF NEUTROPHIL INFLUX AND THE TREATMENT OF BRONCHOPULMONARY DISPLASIA, RESPIRATORY DISTRESS SYNDROME, CHRONIC LUNG DISEASE, PULMONARY FIBROSIS, ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#2615Compositions and methods for restoring or rejuvenating stem/progenitor cell function
#2616Implantable solid dosage form
#2617RNY-derived small RNAs as biomarkers for atherosclerosis-related disorders
#2618Mitochondrial targeting and therapeutic use thereof
#2619Methods for DNA-dependent targeting of a cell permeant antibody
#2620Methods for treating fibrotic cancers
#2621Compounds and methods for the treatment of vascular disease
#2622METHODS OF TREATING DIABETES AND RELATED DISORDERS
#2623Compositions for treating dry eye disease
#2624Technology for the Preparation of Microparticles
#2625Methods for inducing glucose uptake
#2626Dry powder inhaler and system for drug delivery
#2627Methods for treating or reducing the risk of arthritis in a subject by administering gelsolin
#2628S100 based treatment of cardiac power failure
#2629Compositions and Formulations for Prevention and Treatment of Diabetes and Obesity, and Methods of Production and Use Thereof in Glucose and Caloric Control
#2630Regulating calcium in excitable cells with a novel protein
#2631Composition for inhibiting human cytomegalovirus replication
#2632Inhibitors of valosin-containing protein and methods of use
#2633Universal protein tag for double stranded nucleic acid delivery
#2634Method to kill pathogenic microbes in a patient
#2635Immunogenic tumor associated stromal cell antigen peptides and methods of their use
#2636IL-1beta propeptide and IL-1Ra chimera and methods of using the same
#2637Methods and compositions for modulating PD1
#2638Method of preparing induced neural stem cells reprogrammed from non-neuronal cells using HMGA2
#2639Methods for the treatment of neurological disorders and diseases using FNDC5
#2640Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#2641USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION
#2642Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide
#2643Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#2644USE OF DECTIN-1 ACTIVATORS FOR TREATMENT OF LIVER DISORDERS
#2645SRPX for treatment of cancer
#2646Engineered integrin binding peptide compositions
#2647Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#2648Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide
#2649MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) PROMOTER POLYMORPHISM IN INFLAMMATORY DISEASE
#2650Fusion protein comprising albumin and retinol-binding protein
#2651Formulation of MK2 inhibitor peptides
#2652Peptides and uses thereof
#2653Treatment of synucleinopathies
#2654CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#2655USE OF ARPIN A NEW INHIBITOR OF THE ARP2/3 COMPLEX FOR THE DIAGNOSIS AND TREATMENT OF DISEASES
#2656Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
#2657Polypeptide targeting to mitochondria
#2658Biomarkers for seizures
#2659Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl
#2660METHOD FOR TREATING ALS VIA THE INCREASED PRODUCTION OF FACTOR H
#2661METHOD OF TREATING CORAL, A CORAL FOOD COMPOSITION AND A METHOD OF MANUFACTURE
#2662Follistatin-related fusion proteins
#2663Adeno-associated virus virions with variant capsid and methods of use thereof
#2664RASAL1 is a major tumor suppressor gene in thyroid cancer
#2665T-cell redirecting bispecific antibodies for treatment of disease
#2666T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
#2667MPS peptides and use thereof
#2668FILIP1L compositions and methods for treating cancer
#2669USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID SPHINGOLIPID AND CHOLESTEROL
#2670DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS
#2671Antibody multimerization technologies
#2672Use of hepcidin as a regulator of iron homeostasis
#2673Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases
#2674LACTOFERRIN-OSTEOPONTIN-IRON COMPLEX
#2675Methods of treating chronic inflammatory diseases
#2676Cyclic apelin derivatives for the treatment of heart failure
#2677NOVEL NANOLIPOSOMES AND THEIR USE FOR THE TREATMENT OF AMYLOID PROTEIN DISEASES
#2678Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis
#2679GLYCOSYLATED PROTEIN OF AN EXTRA-CELLULAR MATRIX FOR USE IN A METHOD OF TREATING AN ISCHEMIC HEART OF A HUMAN OR ANIMAL SUBJECT IN NEED THEREOF
#2680Nutritional composition for improving brain function in phenylketonuria
#2681Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
#2682LIPOPEPTIDE INHIBITORS OF RAS ONCOPROTEINS
#2683Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use
#2684Amniotic membrane preparations and purified compositions and anti-inflammation methods
#2685CETP antigenic peptide and fusion protein and their composition and applications
#2686Vector(S) Containing an Inducible Gene Encoding a CDK4/CDK6 Inhibitor Useful for Treating Neurodegenerative Disorders or Diseases Associated with an Unscheduled Activation of the Cell Cycle
#2687Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors
#2688Myonectin (CTRP15), compositions comprising same, and methods of use
#2689CLATHRIN THERAPEUTIC FOR PSYCHIATRIC and NEUROPSYCHIATRIC DISORDERS
#2690ADAM22 for use as a prognostic variable, and target for therapy, of a metastatic breast cancer disease
#2691Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#2692Method for producing autologous proteins
#2693BETA-CASEIN A2 AND REDUCING OR PREVENTING SYMPTOMS OF LACTOSE INTOLERANCE
#2694NGAL AND URINARY TRACT INFECTION
#2695Cell populations, methods of transdifferentiation and methods of use thereof
#2696Semaphorin 3A for treatment of systemic lupus erythematosus
#2697Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#2698Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#2699Purified amniotic membrane compositions and methods of use
#2700Method and composition of inducing hair follicle neogenesis